Lighter You review

On the one question this site asks, the answer here is unusually clear and it is the wrong way round: the microdose costs ten dollars more per cycle than the seller's own compounded semaglutide. Taking less does not cost less. There is real substance behind the products — six microdose SKUs, each naming its molecule rather than selling an unlabeled GLP-1, four dispensing pharmacies named with addresses and phone numbers, an oral tablet route, and dietitian visits stated as included — but the pricing does not agree with itself anywhere you look. Tirzepatide is twice as expensive in the store as the marketing site advertises. The oral tablet is quoted two ways. The microdose is promoted at two low figures that match no purchasable product. And every charge is per four weeks while the marketing pages print a monthly slash, which is thirteen charges a year rather than twelve. One term is worth knowing before you start: you are charged when the intake is completed, before a clinician has decided anything, and that is stated only in the refund policy.

Vs median

Not comparable — no per-month rate is published — the verified string carries no monthly figure

Market

$59–$1300/mo is the full published spread in our ranking

Structure

Prices the low dose on its own

Consult

Billed separately

Dietitian

Included

Labs

Not required

Pricing

Varies by dose, plan or tier

Price last updated

September 2026

Lighter You dispenses through a RedRock · Health Warehouse · Precision Compounding · Triad Rx — designation not stated facility. No bloodwork is required before you start. A clinician review is billed separately.

Lighter You sells compounded semaglutide and compounded tirzepatide as injections, an oral semaglutide tablet, and a microdose line of six injectable products that name their molecule individually. On the one question this site exists to answer it gives an unusually clear answer, and it is the wrong way round: the microdose costs ten dollars more per cycle than the company's own full-dose semaglutide. Taking less does not cost less here. The rest of the pricing does not agree with itself either. Tirzepatide is $339 in the store and on the intake while the marketing site advertises it from $169, a difference of a factor of two on the same brand; the oral tablet is $279 in one place and $249 in another; and the microdose is promoted at $96 and $99 on figures that match no purchasable product. Everything is billed per four weeks while the marketing pages print a monthly slash. The company names four dispensing pharmacies with addresses and phone numbers and runs its prescribing through a named telehealth platform, but never says which pharmacy fills an order, states no compounding class, and names no clinician.

THE MICRODOSE COSTS MORE THAN THE FULL DOSE — $179 per four weeks against $169 for the company's own compounded semaglutide

• Tirzepatide is $339 per four weeks in the store and advertised from $169 on the marketing site: a factor of two, live on the same brand
• Every figure is billed per four weeks while the marketing pages print a monthly slash — about thirteen charges a year
• The microdose is promoted at $96 and $99 on figures matching no purchasable product
• You are charged when the intake is completed, before a clinician has decided anything, and that is stated only in the refund policy
• A 30-day satisfaction guarantee in the questions sits against a refund policy saying no refund will be issued on cancellation
• The terms say all fifty states and the District of Columbia while the footer on every page says not available in all fifty states
• No compounding class is stated, no clinician is named, and which of the four pharmacies fills an order is never disclosed
• Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven

Lighter You is one of 393 low-dose GLP-1 programs we track, and 254 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• Low dose vs full dose
• What microdosing GLP-1 costs
• What the evidence actually shows
• What a flat price costs at a low dose
• The true annual cost of a plan